New data reveals the prevalence of chronic swelling and the devastating impact it can have on health-related quality of life. The findings of the study are published in the journal Lymphatic Research and Biology.
Chronic edema caused by the relative failure of the lymphatic system is mistakenly thought of as a rare condition, when, in fact, it is not only a relatively common, universal medical problem, but also very difficult to treat.
Insufficient data have not been available to estimate the size of the affected population and, thus, to support the extensive impact of this disease. In response to this need, the International Lymphoedema Framework coordinated and completed the Lymphedema Impact and Prevalence project (LIMPRINT) on a worldwide scale.
Also featured is the article "LIMPRINT: Health-Related Quality of Life in Adult Patients with Chronic Edema," by Gregoire Mercier, MD, PhD, MSc, CHU de Montpellier and CNRS Université de Montpellier (Montpellier, France) and a team of researchers from Nottingham Trent University (Nottingham, U.K.) and Centre for Research & Implementation of Clinical Practice (London, U.K.). Chronic edema had a considerable impact on patient self-reports of health-related quality of life, and the impact was greater with leg compared to arm chronic edema.
"The nearly universal neglect of lymphedema has been both paradoxical and frustrating to patients and health care providers alike. As the Editor-in-Chief, I am proud to have our journal serve as the publication medium for this important work. The availability of the LIMPRINT data is groundbreaking and should provide a much-needed paradigm shift," says Stanley G. Rockson, MD, Editor-in-Chief of Lymphatic Research and Biology and Allan and Tina Neill Professor of Lymphatic Research and Medicine, Stanford University School of Medicine, CA.